Can GLP-1 receptor agonists be delivered through the skin at all
Lancet 352:854865 Dujic T, Zhou K, Donnelly LA, Tavendale R, Palmer CN, Pearson ER (2015) Association of organic cation transporter 1 with intolerance to metformin in type 2 diabetes: a GoDARTS study
GHK-Cu is typically studied in topical, injectable, or microneedling applications, and is sometimes combined with peptides like BPC-157 or TB-500 to enhance regenerative outcomes
Meet the Experts Hadley King, MD, a board-certified dermatologist based in New York City
The gradual escalation exists because each step allows your GLP-1 receptors, your gut motility, and your neurological appetite circuits to adapt incrementally
It offers hope for low ovarian reserve